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Abstract 
The exact cause of Crohn’s Disease (CD), one of the main types of inflammatory bowel disease 
(IBD), remains an open question. Previous Genome-Wide Association Studies (GWAS) have 
associated Crohn’s disease with >240 genetic loci, but the mechanism behind these associations 
is still unknown. Many of the identified sites lie within the non-coding region of human genome, 
suggesting gene regulatory element as one of the contributors to Crohn’s Disease. From this 
observation, we posed the question that motivated this research: How does genetic variation 
influence chromatin accessibility that may contribute to developing Crohn’s disease? Allelic 
imbalance is a phenomenon where the two alleles of a given gene are expressed at different 
levels in a given cell, either because of epigenetic inactivation of one of the two alleles, or 
because of genetic variation in regulatory regions (Wagner, Pokholok, Gunderson, Pastinen, & 
Blanchette, 2010). We developed a computational pipeline to perform allelic imbalance analysis 
on both Crohn’s disease patients and non-IBD control individuals to discover the correlation 
between chromatin accessibility with different copies of SNP alleles. We performed the analysis 
based on patients’ genotype information and genome-wide, sequencing-based chromatin 
accessibility assay results. 239 sites of allelic imbalance were detected in chromatin accessibility 
data from the CD group, and 273 imbalance sites from the non-IBD group. By comparing the 
identified sites of imbalance with GWAS results and reviewing the function of genes adjacent to 
these imbalanced sites, we identified several sites potentially contributing to Crohn’s disease. 
These identified sites/regions provide interesting targets for future studies to determine the cause 




Although the exact causation of Crohn’s disease is still unknown, strong genetic factors are 
suggested by the occurrence of this disease in families. Trying to understand how genetic factors 
contribute to Crohn’s disease, GWAS studies have associated it with various genetic sites. Many 
of these sites lie within the non-coding region of human genome (Verstockt, Smith, & Lee, 
2018). Since these regions does not participate in protein production, they are more likely to be 
contributing to the disease by regulating the expression level of other genes. From this 
observation, we posed the question that motivated this research: Is chromatin accessibility in 
Crohn’s disease patients influenced by different alleles in single nucleotide polymorphisms 
(SNPs)?  
 
Theoretically, if a SNP is heterozygous at a site where both alleles have the same effect on 
chromatin accessibility, the chromatin is assumed to have equal accessibility at that loci for both 
alleles. To test for chromatin accessibility, the Assay for Transposase-Accessible 
Chromatin(ATAC-seq) was used. It functions by inserting transposase Tn5 into the 
genome.  Regions free of nucleosomes can efficiently add Tn5 and can be isolated and amplified 
by PCR more easily. DNA where Tn5 was added can be sequenced. Therefore, when mapping 
sequencing reads to a reference genome, regions with higher chromatin accessibility are 
expected to have more reads aligned to it. Thus, ATAC-seq reflects chromatin accessibility at a 
certain location by its corresponding read enrichment levels. If the loci with different alleles on 
the two chromosomes have similar chromatin accessibility, both have equal chance to be 
accessed by the Tn5 transposes during ATAC-seq. When the sequence reads were aligned, we 
would expect seeing roughly equal number of reads aligned to each of the alleles at this 
heterozygous site. On the contrary, if there is a significant imbalance between read numbers at 
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the two alleles, it suggests that the allele present at this SNP site affects the chromatin 
accessibility of the region.  
 
However, allelic bias introduced during sequence alignment can be a major problem when 
looking at allele specific expression levels (Stevenson, Coolon, & Wittkopp, 2013). When 
aligning sequencing results, the standard human reference genome such as hg19/hg38 is usually 
used. However, the standard reference genome only contains one variation for each SNP site. 
This would punish reads containing the alternate alleles for their lower similarity, and they 
would become less likely to align to their corresponding position. By favoring one allele over the 
other, reads with the allele contained in the reference genome can be more easily aligned and 
cause false positives when looking for allelic imbalance. Another possible bias source is the 
overlapping ends for paired reads. alleles in the overlapping region may get counted twice when 
measuring for chromatin accessibility. For this study, we established an allelic imbalance 
detection pipeline that can reduce these biases and decrease the false positive rate during 
detection. 
  
Furthermore, by duplicating the experiment process on multiple subjects, we explored whether 
we can discover allelic imbalance at sites specific to and prevalent among Crohn’s disease 
patient population. Such observations would support the hypothesis that these sites are associated 
with Crohn’s disease. More evidence is needed and there are several aspects that we wish to look 
at in future studies --- such as cross-referencing with GWAS results to confirm known 
associations with functions. Also, whether these SNPs influence the expression of target genes of 
accessible chromatin can be tested using experiments such as RNA-seq. If these tests can detect 
	 5	
expression peaks coherent with our result, the connection between these sites and the Crohn’s 





Well-characterized CD patients from the adult IBD Center at University of North Carolina were 
included in this study (IRB Approval # 10-0355, 14-2445 and 11-0359). (Weiser et al., 2016) 
Colon tissue was obtained from each sample. Tissue samples were confirmed by an independent 
pathologist to have no active inflammation, only quiescent colitis. Tissue from non-IBD control 
patients was obtained at time of surgical resection for non-IBD related illness and from a site 
distant from any pathology (Weiser et al., 2016). 12 CD samples and 18 control samples were 
submitted for Assay for Transposase Accessible Chromatin (ATAC) sequencing analyses. In 
addition, all samples were genotyped using the Illumina Immunochip platform, and imputation 
was carried out with the University of Michigan imputation server. (Das et al., 2016) 
 
 




Gender CD non-IBD 
Female 8 11 
Male 4 7 
 12 18 
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Custom reference genome creation 
The personalized reference genome was created for each sample using the standard hg19 
genome. Based on the imputed genotype information, homozygous alternate alleles were directly 
replaced in the hg19 fasta files. (Buchkovich, Eklund, Duan, Li, Mohlke, & Furey, 2015) 
‘Snpindex’ was used to create index files containing heterozygous positions to tolerate these 
SNPs during alignment process (Wu, & Watanabe, 2015).  
 
ATAC-seq and analysis pipeline (FureyWiki, 2019) 
ATAC-seq was performed according to previously described protocol (Buenrostro, Wu, Chang, 
& Greenleaf, 2015). Sequence reads were processed by ‘Cutadapt’ (Martin, 2011) to remove 
adapter sequence. Low quality ends were trimmed before adapter removal. Five matching bases 
between the read and adapter were needed for the adapter removal to be performed. Reads with 
length shorter than 30bps after removal were discarded. FASTX_Toolkit was used to trim reads 
into length of 50 bases, and only keeping reads that have quality higher than 20 for at least 90% 
of its bases. Non-mappable sequences such as linker, barcode, fingerprints are filtered and 




Figure1. ATAC-seq analysis pipeline and parameters used for processing (FureyWiki, 2019). Including parameters 
and the adapter sequence used for each step. 
 
Alignment 
GSNAP was used to align the 50 bp paired-end reads to the customized reference genome (Wu, 
& Watanabe, 2015). Alignment results were referenced with the previously generated list of 
heterozygous SNPs in each individual. Reads containing listed positions would be substituted 
with the alternate allele at these loci. These converted reads were transformed into fastq files and 
re-aligned to the customized reference genome using the same parameters as the original reads. 
Reads aligned to different positions in the second alignment were discarded. Thus, only reads 
aligned uniquely regardless of the allele present were used to detect allelic imbalance 
(Buchkovich, Eklund, Duan, Li, Mohlke, & Furey, 2015).  
	 8	
  
Allelic Imbalance Analyses 
The filtered alignment results were processed with the GATK toolkit (McKenna et al., 2010) 
using the ASEReadCounter function, with the -U ALLOW_N_CIGAR_READS flag used and a 
list of heterozygous positions provided as reference. This function calculates allele counts at a set 
of positions after applying filters that are tuned for enabling allele-specific expression (ASE) 
analysis. The function’s output file contained allele read counts at all heterozygous SNP 
positions. 
 
Imbalance significance was assessed using binomial probability with the p-value threshold set to 
0.05 (Buchkovich, Eklund, Duan, Li, Mohlke, & Furey, 2015). To ensure statistical power, a 
minimum threshold for each allele was set at 5. This makes the smaller count between the two 
alleles of each SNP be at least 5 for the loci to be considered for testing as a significantly 
imbalanced site. With a p-value less than 0.05, it is unlikely that the allelic imbalance was caused 
by chance. However, it has to be noticed that significance in one subject cannot imply 




Establishment of allelic imbalance detection pipeline 
During this study, a next generation sequencing data based pipeline was developed to detect 
allelic imbalance sites. The pipeline takes each sample’s ATAC-seq reads and genotype 
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information as input, and produces the detected imbalance loci and their corresponding p-value 
as the output. 
 
Figure 2. Allelic imbalance detection pipeline process flowchart. The pipeline consists of three main parts: 
customized reference genome creation (blue), allele-aware alignment (green), and allelic imbalance detection (red).  
 
The goal for creating a customized reference genome was to eliminate the allelic bias introduced 
during the alignment. By referencing the standard genome, reads containing alleles not included 
in the reference genome will be penalized due to mismatch and reduced similarity. This bias is 
important for the allelic specific expression level study because it can introduce false positive, 
favoring reads containing same alleles with the reference genome. By creating the customized 
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reference genome, both copy of alleles can receive equal consideration during alignment and 
therefore eliminate this source of bias. 
 
Another source of possible bias is the difference in mappability during alignments based on 
which allele is present (Buchkovich, Eklund, Duan, Li, Mohlke, & Furey, 2015). The allele-
aware alignment step was performed in order to eliminate this bias. For each read that contained 
an heterozygous position during the first alignment, we flipped the allele so that it contained to 
the alternate allele, and performed the alignment again with same reference genome and 
parameters. Comparing this alignment result to the original alignment, we filtered out reads that 
have a changed alignment result. These reads’ alignments were influenced by the allele they 
carry. To exclude the alignment bias, we only kept reads that uniquely aligned to the same 
position regardless of the allele contained. Also, we filtered out reads aligned to multiple 
locations. By doing this, it is possible that we lowered the sensitivity of the detection by filtering 
out reads. But we were trying to ensure that we eliminated as much false positive results as 
possible. 
 
To account for the possible bias introduced by the overlapping ends of paired reads, we used the 
ASEReadcounter from the GATK toolkit (McKenna et al., 2010). Its -U 
ALLOW_N_CIGAR_READS flag automatically removes one copy of the overlapping ends 
during allele counting and therefore prevents counting alleles in these regions twice and which 
can cause false positive signals. A binomial distribution model was used for the significance test. 
We chose the standard p-value threshold of 0.05. On average only 0.004% of reads were 
identified as significant. 
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Allelic imbalance detected in Crohn’s Disease 
The previously described allelic imbalance detection pipeline was used to detect imbalance sites 
potentially related to Crohn’s Disease. Data collected from two groups of sample—Crohn’s 
disease patients and non-IBD controls were ran through the pipeline. 239 allelic imbalance sites 
were detected from the CD group, and 273 imbalance sites from the non-IBD group (Appendix 
A, B). 54 sites were identified in both groups. Among these commonly identified loci, 22 loci 
show different imbalance tendency in two groups (i.e. one copy of allele has higher expression 
level in the non-IBD group but has lower expression level in the CD group compared to the 
alternate copy) (Table 2). 
 
Table 2. Common imbalanced sites with different tendency in CD group and non-IBD group. Numbers shown are 
the reference allele counts versus alternate allele counts of that loci for each group. 
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To further interpret the identified positions, we looked at genes close to them. Since genes close 
to the SNP sites are more likely to be regulated, their function partially reflects what possible 
change in phenotype these alleles, by regulating gene expression, may cause. Because Crohn’s 
disease involves chronic inflammation in the colon tissue, we especially looked for gene 
functions that are connected with immune system pathways. 
 
There are several interesting genes being detected. The GSK3B gene near position 
chr3:119813282 is involved in energy metabolism and inflammation. The TAX1BP1 gene near 
chr 7:27779729 have a role in the inhibition of inflammatory signaling pathways. The PLEC 
gene near chr8:145026450 is related with immune system. Although these gene ontology cannot 
be used as direct evidence for connection with the disease, the related sites should be considered 
to have a higher possibility to contribute. 
 
One of the detected positions especially attracted our attention. The alternate allele on 
chr2:219151926 was detected to have a higher expression level. This loci falls within the intron 
region of gene TMBIM1, which is related to innate immune system pathways. Also, this position 
has been associated with Crohn’s Disease by previous GWAS studies. Suggesting a higher 




The allelic imbalance detection on sequencing data can be used as a tool to identify effects of 
genetic variation on gene regulation, and possibly detect connection between non-coding regions 
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with disease phenotypes (FureyWiki, 2019). In this study, we used it on Crohn’s disease patients, 
trying to identify gene regulation sites that may contribute to the disease. 
 
Among the significant imbalance sites we detected, we found chr2:219151926 especially 
interesting. Its correlation with Crohn’s Disease was corroborated by GWAS results as well as 
gene ontology. This SNP position was identified to be an eQTL loci in colon tissue for gene 
TMBIM1. TMBIM1 negatively regulates MPP9, which is a gene commonly being up-regulated 
in IBD patients. According to our discovery and these previous studies, we hypothesized that a 
higher accessibility in one of the copies means a regulatory factor, likely an enhancer for 
TMBIM1, have less binding to this position due to the presence of the alternate allele. Therefore, 
it is possible that TMBIM1 gets suppressed and MPP9 gets up-regulated. However, because this 
imbalance was only detected in one sample from the CD group, we have no strong evidence to 
directly prove its association with Crohn’s Disease. 
 
There are several other detected sites close to genes relevant to the immunization pathway. Thus, 
if these genes are regulated by the SNPs, the regulation of their expression may send abnormal 
signals to the immunization system, causing it to respond as if there is an infection. Or, the 
regulation might cause an overexpression in immunization behavior in the form of constant 
inflammation. Those possibilities provide a potential link between these sites and the disease 
phenotype. 
 
Again, with all the imbalance sites only identified in one samples, we could not verify the 
hypothesis that those sites are connected with the Crohn’s disease. The study can be improved by 
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expanding group size to avoid bias and by combining reads from different subjects for more 
statistical power. Given these improvements, a future study will provide a better evidence on 
whether the allelic imbalance sites may contribute to the Crohn’s disease by regulating gene 
expression or not. 
 
Possible future improvements  
 
One of the most important limiting factors to the established pipeline is the sequencing depth for 
each subject. Sequencing depth influences the statistical power of our imbalance detection, so 
that by increasing the sequencing depth, more statistical power can be granted to our test, 
providing more reliable results. One way of improving statistical power for our test is, instead of 
using individual reads, combine reads from multiple subjects for imbalance detection. With reads 
from multiple subjects, one thing that we can avoid is subject bias, such as imbalanced sites that 
are only significant in specific subject due to conditions other than Crohn’s disease. These 
subject specific imbalance reads are likely to be diluted by balanced reads from other subjects 
and therefore lose significance, leaving the imbalance sites that are prevalent among population. 
Finally, since more reads are present, larger differences between allelic counts is needed for the 
imbalance to be significant.  
 
If, with future studies, we can determine whether these imbalanced loci in non-coding regions 
contribute to Crohn’s disease by regulating nearby genes’ expression, we can gain a better 
understanding of the cause of Crohn’s Disease. Also, further research on this subject can help 
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with the unclassified IBD problem by classifying patients according to genetic resemblance in 
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